J. Balldin et al., 6-MONTH OPEN TRIAL WITH ZIMELIDINE IN ALCOHOL-DEPENDENT PATIENTS - REDUCTION IN DAYS OF ALCOHOL INTAKE, Drug and alcohol dependence, 35(3), 1994, pp. 245-248
In an open study, 14 alcohol-dependent male patients were treated with
the selective serotonin reuptake inhibitor (SSRI) Zimelidine, 200 mg
daily, for six months. They were given psychosocial therapy before and
during the study. The number of days of alcohol intake was statistica
lly significantly reduced from a mean of 14 days per month before to 1
-5 days during drug treatment. No effect was observed on the amount of
daily alcohol intake on drinking days. No tolerance to the effect of
Zimelidine was observed during the study. The findings suggest an effe
ct of combined psychosocial support with SSRI treatment that seems to
be of clinical significance.